Uzbekistan has signed a deal with a Maltese company, Melabis, to produce medical cannabis in the Central Asian country, RFE/RL reported. According to government officials, Melabis will grow the plants on 3,000 hectares of farmland in the Sardoba district of Uzbekistan’s Sirdaryo Province. According to the state news agency UzA, the refined product will have THC content of 0.1-0.2 percent, making it suitable only for medical use. “The final product will be mostly exported,” UzA said. With an initial investment of about $33 million, the project includes building a high-tech plant and laboratories in Sirdaryo that would create some 100 new jobs, UzA reported.

Mmp News Author, Medical Marijuana Program Connection, 11/27/2020 02:07:23

Open article: